Invitrogen™ Betamethasone Recombinant Mouse Monoclonal Antibody (2D5)

Betamethasone is a potent systemic corticosteroid used primarily to alleviate inflammation in various conditions, including allergic states, dermatologic disorders, gastrointestinal diseases, and hematological disorders. It is often administered in nano-based drug delivery systems to enhance drug release and permeability, reduce dosage, and minimize toxicity. Betamethasone's effectiveness in treating chronic inflammatory skin disorders such as psoriasis and atopic dermatitis is well-documented, with ongoing research focused on improving its delivery and efficacy. The biosimilar market for betamethasone is evolving, with strategies aimed at increasing adoption and addressing safety concerns related to switching from reference biologics to biosimilars. Betamethasone has demonstrated decreased risks for respiratory distress syndrome, intraventricular hemorrhage, and neonatal infections compared to dexamethasone, highlighting its therapeutic advantages.